Associate Professor of Medicine, Harvard Medical School Massachusetts General Hospital
Infectious Disease
Dr. Gregory K. Robbins, MD
|
|
Give Review
Gregory K. Robbins works in the field of Infectious Disease. He went to Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. Gregory Robbins has written publications. He has 45 publications published with PubMed. The lastest paper is: 'Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).' Doctor Gregory K. Robbins, MD accepts Medicare.
Publications
- Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
- Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).
- Body image disturbance and health behaviors among sexual minority men living with HIV.
- Reflections on living with HIV over time: exploring the perspective of HIV-infected women over 50.
- Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
- Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis.
- Higher Expression of Several Interferon-Stimulated Genes in HIV-1-Infected Females After Adjusting for the Level of Viral Replication.
- Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance test...
- Intimacy and Sexual Decision Making: Exploring the Perspective of HIV Positive Women Over 50.
- Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
- Varicella zoster mimicking infectious tenosynovitis.
- Designing Interventions to Overcome Poor Numeracy and Improve Medication Adherence in Chronic Illness, Including HIV/Aids.
- Real-Time Electronic Adherence Monitoring is Feasible, Comparable to Unannounced Pill Counts, and Acceptable.
- Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.
- Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain.
- Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.
- Ocular syphilis among HIV-infected individuals.
- Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral t...
- Predicting virologic failure in an HIV clinic.
- Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.
- Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.
- Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.
- Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
- Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.
- Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
- Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical T...
- Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
- Predictors of antiretroviral treatment failure in an urban HIV clinic.
- Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.
- Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection.
- Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.
- Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).
- Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.
- Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.
- Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection.
- Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.
- Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
- Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.
- High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.
- Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.
- Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.
- BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient.
- Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
- Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.
Schools
Boston University School Of Medicine
Cornell Med Center
Massachusetts General Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Massachusetts General Hospital -
New York Presbyterian Hospital - Cornell Campus -
Boston University School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1811977911 | |
| NPPES Provider LastName | ROBBINS | |
| NPPES Provider FirstName | GREGORY | |
| NPPES Provider ZIPCode | 021142696 | |
| NPPES Provider State | MA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 2246.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 49.0 | |
| Percent Opioid Claims | 2.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811977911 |
| Last Name Of The Provider | ROBBINS |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Marcia B. Goldberg, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Marylyn M. Addo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Michael K. Mansour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew D. Luster, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brian L. Hollenbeck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raphael Dolin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn D. Alonso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose M. Trevejo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry J. Donaghy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lorne N. Small, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin R. Ingalls, MD
This Doctor is OpenDoctor Recommended.
|